288 related articles for article (PubMed ID: 26690130)
1. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.
Shalaby T; Grotzer MA
Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
Kopkova A; Sana J; Fadrus P; Slaby O
Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.
Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
Cancer Sci; 2018 Sep; 109(9):2651-2659. PubMed ID: 29949235
[TBL] [Abstract][Full Text] [Related]
4. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in Cerebrospinal Fluid as Biomarkers in Brain Tumor Patients.
Kopková A; Šána J; Večeřa M; Fadrus P; Lipina R; Smrčka M; Lojová M; Slabý O
Klin Onkol; 2019; 32(3):181-186. PubMed ID: 31216849
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.
Teplyuk NM; Mollenhauer B; Gabriely G; Giese A; Kim E; Smolsky M; Kim RY; Saria MG; Pastorino S; Kesari S; Krichevsky AM
Neuro Oncol; 2012 Jun; 14(6):689-700. PubMed ID: 22492962
[TBL] [Abstract][Full Text] [Related]
7. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
Verheul C; Kleijn A; Lamfers MLM
Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
[TBL] [Abstract][Full Text] [Related]
9. Expression of microRNAs in cerebrospinal fluid of dogs with central nervous system disease.
Marioni-Henry K; Zaho D; Amengual-Batle P; Rzechorzek NM; Clinton M
Acta Vet Scand; 2018 Dec; 60(1):80. PubMed ID: 30563542
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma multiforme with epithelial differentiation: a potential diagnostic pitfall in cerebrospinal fluid cytology.
Gill SK; Padmanabhan V; Hickey WF; Marotti JD
Diagn Cytopathol; 2015 Aug; 43(8):638-41. PubMed ID: 25913842
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
[TBL] [Abstract][Full Text] [Related]
12. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
Bach F; Soletormos G; Dombernowsky P
J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
[TBL] [Abstract][Full Text] [Related]
13. [Usage of Cerebrospinal Fluid for microRNA Analysis].
Kopková A; Šána J; Večeřa M; Knoflíčková D; Smrčka M; Slabý O; Fadrus P
Klin Onkol; 2018; 31(Supplementum1):158-160. PubMed ID: 29808693
[TBL] [Abstract][Full Text] [Related]
14. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies.
Katopodis N; Glantz MJ; Kim L; Dafni U; Wu JK; Perides G
Cancer; 2001 Aug; 92(4):856-62. PubMed ID: 11550158
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
Mikolajewicz N; Yee PP; Bhanja D; Trifoi M; Miller AM; Metellus P; Bagley SJ; Balaj L; de Macedo Filho LJM; Zacharia BE; Aregawi D; Glantz M; Weller M; Ahluwalia MS; Kislinger T; Mansouri A
J Clin Oncol; 2024 Jun; 42(16):1961-1974. PubMed ID: 38608213
[TBL] [Abstract][Full Text] [Related]
16. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
17. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder.
Wan Y; Liu Y; Wang X; Wu J; Liu K; Zhou J; Liu L; Zhang C
PLoS One; 2015; 10(3):e0121975. PubMed ID: 25763923
[TBL] [Abstract][Full Text] [Related]
18. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
Nevel KS; Wilcox JA; Robell LJ; Umemura Y
Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors.
Kopkova A; Sana J; Machackova T; Vecera M; Radova L; Trachtova K; Vybihal V; Smrcka M; Kazda T; Slaby O; Fadrus P
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614872
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid-based metabolomics to characterize different types of brain tumors.
Wang FX; Chen K; Huang FQ; Alolga RN; Ma J; Wu ZX; Fan Y; Ma G; Guan M
J Neurol; 2020 Apr; 267(4):984-993. PubMed ID: 31822990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
